Mitochondrial DNA Depletion Syndromes: Review and Updates of Genetic Basis, Manifestations, and Therapeutic Options

Moraes, 1991, MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases, Am J Hum Genet, 48, 492

Sarzi, 2007, Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood, J Pediatr, 150, 531, 10.1016/j.jpeds.2007.01.044

Spinazzola, 2009, Clinical and molecular features of mitochondrial DNA depletion syndromes, J Inherit Metab Dis, 32, 143, 10.1007/s10545-008-1038-z

Suomalainen, 2010, Mitochondrial DNA depletion syndromes—many genes, common mechanisms, Neuromuscul Disord, 20, 429, 10.1016/j.nmd.2010.03.017

Spinazzola, 2011, Mitochondrial DNA mutations and depletion in pediatric medicine, Semin Fetal Neonatal Med, 16, 190, 10.1016/j.siny.2011.04.011

Johansson, 1997, Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2, J Biol Chem, 272, 8454, 10.1074/jbc.272.13.8454

Johansson, 1996, Cloning and expression of human deoxyguanosine kinase cDNA, Proc Nat Acad Sci, 93, 7258, 10.1073/pnas.93.14.7258

Kowluru, 2002, Localization and characterization of the mitochondrial isoform of the nucleoside diphosphate kinase in the pancreatic beta cell: evidence for its complexation with mitochondrial succinyl-CoA synthetase, Arch Biochem Biophys, 398, 160, 10.1006/abbi.2001.2710

Pontarin, 2008, Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage, Proc Natl Acad Sci, 105, 17801, 10.1073/pnas.0808198105

Lecrenier, 1997, Mitochondrial DNA polymerases from yeast to man: a new family of polymerases, Gene, 185, 147, 10.1016/S0378-1119(96)00663-4

Spelbrink, 2001, Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria, Nat Genet, 28, 223, 10.1038/90058

Dallabona, 2010, Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator, Hum Mol Genet, 19, 1098, 10.1093/hmg/ddp581

Pons, 1996, Mitochondrial myopathy simulating spinal muscular atrophy, Pediatr Neurol, 15, 153, 10.1016/0887-8994(96)00118-X

Galbiati, 2006, New mutation in TK2 gene associated with mitochondrial DNA depletion, Pediatr Neurol, 34, 177, 10.1016/j.pediatrneurol.2005.07.013

Oskoui, 2006, Clinical spectrum of mitochondrial DNA depletion due to mutation in the thymidine kinase 2 gene, Arch Neurol, 63, 1122, 10.1001/archneur.63.8.1122

Blakely, 2008, Novel mutationin the TK2 gene associated with fatal mitochondrial DNA depletion myopathy, Neuromuscul Disord, 18, 557, 10.1016/j.nmd.2008.04.014

Gotz, 2008, Thymidine kinase 3 defects can cause multi-tissue mtDNA depletion syndrome, Brain, 131, 2841, 10.1093/brain/awn236

Collins, 2009, Progressive myofiber loss with extensive fibro-fatty replacement in a child with mitochondrial DNA depletion syndrome and novel thymidine kinase 2 gene mutations, Neuromuscul Disord, 19, 784, 10.1016/j.nmd.2009.08.002

Zhang, 2010, Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion, Mol Genet Metab, 99, 53, 10.1016/j.ymgme.2009.09.003

Lesko, 2010, Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion, Neuromuscul Disord, 20, 198, 10.1016/j.nmd.2009.11.013

Martí, 2010, Hearing loss in a patient with the myopathic form of mitochondrial DNA depletion syndrome and novel mutation in the TK2 gene, Pediatr Res, 68, 151, 10.1203/PDR.0b013e3181e33bbe

Behim, 2012, Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum, Neurology, 78, 644, 10.1212/WNL.0b013e318248df2b

Tyynismaa, 2012, Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions, Hum Mol Genet, 21, 66, 10.1093/hmg/ddr438

Elpeleg, 2005, Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion, Am J Hum Genet, 76, 1081, 10.1086/430843

Carrozzo, 2007, SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness, Brain, 130, 862, 10.1093/brain/awl389

Ostergaard, 2007, Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations, Brain, 130, 853, 10.1093/brain/awl383

Ostergaard, 2007, Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion, Am J Hum Genet, 81, 383, 10.1086/519222

Morava, 2009, Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children, Mitochondrion, 9, 438, 10.1016/j.mito.2009.08.003

Ostergaard E. SUCLA2-related mitochondrial DNA depletion syndrome, encephalomyopathic form, with mild methylmalonic aciduria. In: GeneReviews™ [online]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK6803/. Updated 26 May 2009. Accessed 14 Nov 2012.

Ostergaard, 2010, A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria, Eur J Pediatr, 169, 201, 10.1007/s00431-009-1007-z

Bourdon, 2007, Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion, Nat Genet, 39, 776, 10.1038/ng2040

Bornstein, 2008, Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene, Neuromuscul Disord, 18, 453, 10.1016/j.nmd.2008.04.006

Acham-Roschitz, 2009, A novel mutation of the RRM2B gene in an infant with early fatal encephalomyopathy, central hypomyelination, and tubulopathy, Mol Genet Metab, 98, 300, 10.1016/j.ymgme.2009.06.012

Kollberg, 2009, A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion, Neuromuscul Disord, 19, 147, 10.1016/j.nmd.2008.11.014

Shaibani, 2009, Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B, Arch Neurol, 66, 1028, 10.1001/archneurol.2009.139

Tyynismaa, 2009, A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions, Am J Hum Genet, 85, 290, 10.1016/j.ajhg.2009.07.009

Fratter, 2011, RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions, Neurology, 76, 2032, 10.1212/WNL.0b013e31821e558b

Scaglia

Ducluzeau, 1999, Depletion of mitochondrial DNA associated with infantile cholestasis and progressive liver fibrosis, J Hepatol, 30, 149, 10.1016/S0168-8278(99)80019-1

Mandel, 2001, The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA, Nat Genet, 29, 337, 10.1038/ng746

Salviati, 2002, Mitochondrial DNA depletion and dGK gene mutations, Ann Neurol, 52, 311, 10.1002/ana.10284

Taanman, 2002, A novel mutation in the deoxyguanosine kinase gene causing depletion of mitochondrial DNA, Ann Neurol, 52, 237, 10.1002/ana.10247

Filosto, 2004, Hepato-cerebral syndrome: genetic and pathological studies in an infant with a dGK mutation, Acta Neuropathol, 108, 168, 10.1007/s00401-004-0872-9

Rabinowitz, 2004, Hepatocerebral mitochondrial DNA depletion syndrome: clinical and morphologic features of a nuclear gene mutation, J Pediatr Gastroenterol Nutr, 38, 216, 10.1097/00005176-200402000-00022

Labarthe, 2005, Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency, J Hepatol, 43, 333, 10.1016/j.jhep.2005.03.023

Mancuso, 2005, New DGK gene mutations in the hepatocerebral form of mitochondrial DNA depletion syndrome, Arch Neurol, 62, 745, 10.1001/archneur.62.5.745

Slama, 2005, Deoxyguanosine kinase mutations and combined deficiencies of the mitochondrial respiratory chain in patients with hepatic involvement, Mol Genet Metab, 86, 462, 10.1016/j.ymgme.2005.09.006

Tadiboyina, 2005, Novel mutation in DGUOK in hepatocerebral mitochondrial DNA depletion syndrome associated with cystathioninuria, Am J Med Genet A, 135, 289, 10.1002/ajmg.a.30748

Wang, 2005, Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes, Mol Genet Metab, 84, 75, 10.1016/j.ymgme.2004.09.005

Freisinger, 2006, Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations, Arch Neurol, 63, 1129, 10.1001/archneur.63.8.1129

Alberio, 2007, Depletion of mtDNA: syndromes and genes, Mitochondrion, 7, 6, 10.1016/j.mito.2006.11.010

Mousson de Camaret, 2007, Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion, Biochem J, 402, 377, 10.1042/BJ20060705

Dimmock, 2008, Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency, Liver Transpl, 14, 1480, 10.1002/lt.21556

Dimmock, 2008, Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase, Hum Mutat, 29, 330, 10.1002/humu.9519

Lee, 2009, Simultaneous detection of mitochondrial DNA depletion and single-exon deletion in the deoxyguanosine gene using array-based comparative genomic hybridisation, Arch Dis Child, 94, 55, 10.1136/adc.2008.139584

Hanchard, 2011, Deoxyguanosine kinase deficiency presenting as neonatal hemochromatosis, Mol Genet Metab, 103, 262, 10.1016/j.ymgme.2011.03.006

Ronchi, 2012, Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions, Brain, 135, 3404, 10.1093/brain/aws258

Mandel, 2001, The hepatic mitochondrial DNA depletion syndrome: ultrastructural changes in liver biopsies, Hepatology, 34, 776, 10.1053/jhep.2001.27664

Spinazzola, 2006, MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion, Nat Genet, 38, 570, 10.1038/ng1765

Karadimas, 2006, Navajo neurohepatopathy is caused by a mutation in the MPV17 gene, Am J Hum Genet, 79, 544, 10.1086/506913

Wong, 2007, Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy, Hepatology, 46, 1218, 10.1002/hep.21799

Navarro-Sastre, 2008, Lethal hepatopathy and leukodystrophy caused by a novel mutation in MPV17 gene: description of an alternative MPV17 spliced form, Mol Genet Metab, 94, 234, 10.1016/j.ymgme.2008.01.012

Spinazzola, 2008, Hepatocerebral form of mitochondrial DNA depletion syndrome: novel MPV17 mutations, Arch Neurol, 65, 1108, 10.1001/archneur.65.8.1108

Kaji, 2009, Fluctuating liver functions in siblings with MPV17 mutations and possible improvement associated with dietary and pharmaceutical treatments targeting respiratory chain complex II, Mol Genet Metab, 97, 292, 10.1016/j.ymgme.2009.04.014

Parini, 2009, Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients, J Hepatol, 50, 215, 10.1016/j.jhep.2008.08.019

El-Hattab, 2010, MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: new patients and novel mutations, Mol Genet Metab, 99, 300, 10.1016/j.ymgme.2009.10.003

Merkle, 2012, MR imaging findings in the reticular formation in siblings with MPV17-related mitochondrial depletion syndrome, AJNR Am J Neuroradiol, 33, E34, 10.3174/ajnr.A2455

El-Hattab

Blakely, 2012, MPV17 mutation causes neuropathy and leukoencephalopathy with multiple mtDNA deletions in muscle, Neuromuscul Disord, 22, 587, 10.1016/j.nmd.2012.03.006

Van Goethem, 2001, Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions, Nat Genet, 28, 211, 10.1038/90034

Lamantea, 2002, Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia, Ann Neurol, 52, 211, 10.1002/ana.10278

Van Goethem, 2003, Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia, Neuromuscul Disord, 13, 133, 10.1016/S0960-8966(02)00216-X

Filosto, 2003, Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma, Arch Neurol, 60, 1279, 10.1001/archneur.60.9.1279

Finsterer, 2012, Epilepsy in mitochondrial disorders, Seizure., 21, 316, 10.1016/j.seizure.2012.03.003

Rahman, 2012, Mitochondrial disease and epilepsy, Dev Med Child Neurol, 54, 397, 10.1111/j.1469-8749.2011.04214.x

Fadic, 1997, Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease, Neurology, 49, 239, 10.1212/WNL.49.1.239

Winterthun, 2005, Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations, Neurology, 64, 1204, 10.1212/01.WNL.0000156516.77696.5A

Hakonen, 2005, Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin, Am J Hum Genet, 77, 430, 10.1086/444548

Tzoulis, 2006, The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases, Brain, 129, 1685, 10.1093/brain/awl097

Worle, 1998, Progressive cerebral degeneration of childhood with liver disease (Alpers-Huttenlocher disease) with cytochrome oxidase deficiency presenting with epilepsia partialis continua as the first clinical manifestation, Clin Neuropathol, 17, 63

Naviaux, 1999, Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers syndrome, Ann Neurol, 45, 54, 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B

Gauthier-Villars, 2001, Respiratory chain deficiency in Alpers syndrome, Neuropediatrics, 32, 150, 10.1055/s-2001-16614

Naviaux, 2004, POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion, Ann Neurol, 55, 706, 10.1002/ana.20079

Ferrari, 2005, Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA, Brain, 128, 723, 10.1093/brain/awh410

Nguyen, 2005, POLG mutations in Alpers syndrome, Neurology, 65, 1493, 10.1212/01.wnl.0000182814.55361.70

Nguyen, 2006, Molecular diagnosis of Alpers syndrome, J Hepatol, 45, 108, 10.1016/j.jhep.2005.12.026

Horvath, 2006, Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene, Brain, 129, 1674, 10.1093/brain/awl088

Wong, 2008, Molecular and clinical genetics of mitochondrial diseases due to POLG mutations, Hum Mutat, 29, E150, 10.1002/humu.20824

Milone, 2011, POLG-related disorders: defects of the nuclear and mitochondrial genome interaction, Neurology, 77, 1847, 10.1212/WNL.0b013e318238863a

Cohen

Tang, 2012, Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations, J Neurol, 259, 862, 10.1007/s00415-011-6268-6

Darin, 2001, The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities, Ann Neurol, 49, 377, 10.1002/ana.75

Koskinen, 1994, Infantile onset spinocerebellar ataxia with sensory neuropathy: a new inherited disease, J Neurol Sci, 121, 50, 10.1016/0022-510X(94)90156-2

Koskinen, 1994, Sensory neuropathy in infantile onset spinocerebellar ataxia (IOSCA), Muscle Nerve., 17, 509, 10.1002/mus.880170507

Koskinen, 1995, Primary hypogonadism in females with infantile onset spinocerebellar ataxia, Neuropediatrics, 26, 263, 10.1055/s-2007-979769

Koskinen, 1995, Infantile-onset spinocerebellar ataxia: MR and CT findings, AJNR Am J Neuroradiol, 16, 1427

Hartley, 2012, Novel autosomal recessive c10orf2 mutations causing infantile-onset spinocerebellar ataxia, Case Rep Pediatr, 2012, 303096

Kiechl, 2004, Two families with autosomal dominant progressive external ophthalmoplegia, J Neurol Neurosurg Psychiatry, 75, 1125, 10.1136/jnnp.2003.025890

Jeppesen, 2008, Phenotype and clinical course in a family with a new de novo Twinkle gene mutation, Neuromuscul Disord, 18, 306, 10.1016/j.nmd.2007.10.007

Virgilio, 2008, Novel Twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia, J Neurol, 255, 1384, 10.1007/s00415-008-0926-3

Sarzi, 2007, Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion, Ann Neurol, 62, 579, 10.1002/ana.21207

Hakonen, 2007, Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion, Brain, 130, 3032, 10.1093/brain/awm242

Shoffner

Hirano, 1994, Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder, Neurology, 44, 721, 10.1212/WNL.44.4.721

Papadimitriou, 1998, Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome, Neurology, 51, 1086, 10.1212/WNL.51.4.1086

Perez-Atayde, 1998, Mitochondrial neurogastrointestinal encephalomyopathy: diagnosis by rectal biopsy, Am J Surg Pathol, 22, 1141, 10.1097/00000478-199809000-00014

Nishino, 1999, Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder, Science, 283, 689, 10.1126/science.283.5402.689

Nishino, 2000, Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations, Ann Neurol, 47, 792, 10.1002/1531-8249(200006)47:6<792::AID-ANA12>3.0.CO;2-Y

Teitelbaum, 2002, Diagnosis and management of MNGIE syndrome in children: case report and review of the literature, J Pediatr Gastroenterol Nutr, 35, 377, 10.1097/00005176-200209000-00029

Vissing, 2002, Multiple mtDNA deletions with features of MNGIE, Neurology, 59, 926, 10.1212/WNL.59.6.926

Nishigaki, 2003, Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency, J Clin Invest, 111, 1913, 10.1172/JCI17828

Marti, 2004, Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays, Clin Chem, 50, 120, 10.1373/clinchem.2003.026179

Hirano, 2004, Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes, Neurologist, 10, 8, 10.1097/01.nrl.0000106919.06469.04

Blondon, 2005, Digestive smooth muscle mitochondrial myopathy in patients with mitochondrial-neuro-gastro-intestinal encephalomyopathy (MNGIE), Gastroenterol Clin Biol, 29, 773, 10.1016/S0399-8320(05)86346-8

Giordano, 2006, Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine, Gastroenterology, 130, 893, 10.1053/j.gastro.2006.01.004

Giordano, 2008, Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion, Am J Pathol, 173, 1120, 10.2353/ajpath.2008.080252

Finsterer, 2009, Mitochondrial disorders, cognitive impairment and dementia, J Neurol Sci, 283, 143, 10.1016/j.jns.2009.02.347

Finsterer, 2011, Inherited mitochondrial neuropathies, J Neurol Sci, 304, 9, 10.1016/j.jns.2011.02.012

Wong, 2012, Mitochondrial syndromes with leukoencephalopathies, Semin Neurol, 32, 55, 10.1055/s-0032-1306387

Szigeti, 2004, MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation, J Med Genet, 41, 125, 10.1136/jmg.2003.013789

Bicknese, 1992, Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity, Ann Neurol, 32, 767, 10.1002/ana.410320610

Saneto, 2010, POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders, Seizure, 19, 140, 10.1016/j.seizure.2010.01.002

Feranchak, 2007, Medical and nutritional management of cholestasis in infants and children, 190

Hasselmann, 2010, Cerebral folate deficiency and CNS inflammatory markers in Alpers disease, Mol Genet Metab, 99, 58, 10.1016/j.ymgme.2009.08.005

Gold, 2001, Treatment of mitochondrial cytopathies, Semin Neurol, 21, 309, 10.1055/s-2001-17948

Rodriguez, 2007, Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders, Muscle Nerve, 35, 235, 10.1002/mus.20688

Saito, 2012, Pyruvate therapy for mitochondrial DNA depletion syndrome, Biochim Biophys Acta, 1820, 632, 10.1016/j.bbagen.2011.08.006

Bulst, 2012, In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion, Mol Genet Metab, 107, 95, 10.1016/j.ymgme.2012.04.022

Kelly, 2000, Liver transplantation: to do or not to do?, Pediatr Transplant, 4, 170, 10.1034/j.1399-3046.2000.00125.x

Lara, 2007, Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches, Biosci Rep, 27, 151, 10.1007/s10540-007-9043-2

Yavuz, 2007, Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis, Arch Neurol, 64, 435, 10.1001/archneur.64.3.435

Lara, 2006, Infusion of platelets transiently reduces nucleoside overload in MNGIE, Neurology, 67, 1461, 10.1212/01.wnl.0000239824.95411.52

Hirano, 2006, Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE, Neurology, 67, 1458, 10.1212/01.wnl.0000240853.97716.24

Rahman, 2007, Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE, Neurology, 68, 1872, 10.1212/01.wnl.0000265356.98295.be

Halter, 2011, Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach, Bone Marrow Transplant, 46, 330, 10.1038/bmt.2010.100

Filosto, 2012, Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy, J Neurol, 259, 2699, 10.1007/s00415-012-6572-9